Nanning Maple Leaf Pharmaceuticals

Nanning Maple Leaf Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company and a wholly-owned subsidiary of WEX Pharmaceuticals Inc., which is part of the CK Life Sciences group. Based in Nanning, Guangxi, the company serves as the primary manufacturing and research facility for the development of Tetrodotoxin (TTX), a potent sodium channel blocker derived from pufferfish. Its lead product candidate, Tectin (also known as Halneuron), is being evaluated in late-stage clinical trials for the treatment of moderate to severe cancer-related pain and chemotherapy-induced neuropathic pain. In addition to its specialized work with marine toxins, the company has historically manufactured and marketed generic pharmaceutical products in the Chinese market.